Is Your Sunscreen Still Safe? What Australia’s Latest TGA Review Actually Means
Sunscreen is one of those products I use without wanting to overthink every ingredient on the label. But when Australia’s Therapeutic Goods Administration (TGA) announces a safety review of a sunscreen ingredient, it naturally gets attention.
On 11 September 2026, the TGA announced that it is consulting on additional controls for 4-methylbenzylidene camphor (4-MBC), an active ingredient used in some Australian sunscreens.
That sounds worrying at first. But there is an important distinction: this is not an announcement telling Australians to stop using sunscreen. The TGA has specifically said that Australians should continue to use sunscreen and that it is not currently proposing warnings, bans or recalls of sunscreen products as part of this announcement.
So what exactly is being reviewed, and what does it mean for people buying sunscreen in Australia?
1. What Is 4-MBC?
4-MBC is short for 4-methylbenzylidene camphor. It is an active sunscreen ingredient used in some therapeutic sunscreens.
Its job is to help protect skin from ultraviolet radiation. In its safety review, the TGA describes 4-MBC as a UV filter and examined both its ability to penetrate the skin and its potential effects when exposure is considered over time.
Importantly, the current discussion is about one particular sunscreen ingredient. It should not be interpreted as evidence that sunscreen in general is unsafe.
2. Why Is the TGA Reviewing It?
The TGA says its review was prompted by regulatory decisions made overseas. It considered international safety assessments and scientific publications alongside its own assessment using the Australian Sunscreen Exposure Model.
The review considered whether 4-MBC can penetrate the skin and reach viable cells, as well as its potential toxicity.
The TGA says the proposal to restrict the amount of 4-MBC permitted in sunscreens is a precautionary measure. It also explains that the potential safety signals behind the proposal come from animal studies rather than human studies.
This distinction matters. A safety review does not automatically mean that normal use of an existing product has suddenly been shown to cause harm in people.
3. What Is the TGA Actually Proposing?
This is where the headlines can become confusing.
The public consultation opened on 11 September 2026 and is scheduled to close on 12 October 2026. Three different regulatory options are being considered.
Two options proposed by the TGA Delegate would introduce limits on the concentration and use of 4-MBC. A third option, submitted by private applicants, proposes prohibiting 4-MBC in therapeutic goods and cosmetic products.
These are proposals under consultation, not final decisions.
Public submissions will be considered as part of the regulatory process, including consideration by the relevant advisory committees. An interim decision may follow before any final regulatory decision is made.
4. Is 4-MBC Being Banned or Recalled?
Not as a result of the TGA’s 11 September announcement.
The TGA explicitly states that it is not proposing a change in the use of sunscreen or announcing warnings, bans or recalls of products in this announcement.
One of the options being considered during the consultation does propose prohibiting 4-MBC, but that proposal should not be confused with a decision that has already been made.
For consumers, that difference is probably the most important part of this story.
5. What Should Australian Consumers Do Now?
For now, the TGA’s advice is straightforward: Australians should continue to use sunscreen.
The regulator also recommends combining sunscreen with other forms of sun protection, including seeking shade and wearing protective clothing, hats and sunglasses.
If you are particularly concerned about an ingredient in a sunscreen you use, you can check the product label and follow future TGA updates as the consultation progresses. People with specific health concerns can also discuss them with an appropriate healthcare professional.
What I would not do is stop using sun protection because of a headline about an ingredient review. That would miss the main message of the TGA’s own announcement.
6. The Bigger Picture for Sunscreen
I actually find reviews like this reassuring rather than alarming. Sunscreen ingredients are not something regulators approve once and then never look at again. Scientific evidence develops, exposure models improve and international regulatory decisions can trigger another look at existing ingredients.
That does not mean every safety review will result in a ban. Sometimes regulators reduce permitted concentrations, introduce conditions of use, change labelling requirements or decide that existing controls remain appropriate.
For Australian consumers, the useful habit is not to panic every time an ingredient appears in the news. It is to separate what is being investigated, what has actually been decided and what the regulator currently recommends.
In the case of 4-MBC, the review is real and possible additional controls are being considered. But as of September 2026, the consultation is still underway.
And the current message from Australia’s sunscreen regulator remains clear: sun protection still matters.
Sources & Further Reading
Therapeutic Goods Administration — Safety review of 4-Methylbenzylidene Camphor (4-MBC)
Therapeutic Goods Administration — Public consultation on proposed amendments relating to 4-MBC
This article is for general information only and is not medical advice. Sunscreen regulations and recommendations can change as regulatory reviews progress. For current Australian guidance, refer to the Therapeutic Goods Administration or an appropriate healthcare professional.
